Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
82203021
Funder:
National Natural Science Foundation of China
Topic:
Cancer Immunotherapy and Biomarkers
Subfield:
Oncology
Field:
Medicine
Domain:
Health Sciences
Funded outputs count:
3
Funder award ID:
82203021
OpenAlex ID:
G8246306200
Computational methods for cell–cell communication via single cells
2026
·
Haochen Li
, Xiaoxiang Zhou
, et al.
·
Nature Methods
Multi-omics profiling identifies a CXCL9-PD-1 + CD8 + T cell axis for prediction of checkpoint inhibitor pneumonitis
2026
·
Nan Bi
, Ziming Jiang
, et al.
·
European Respiratory Journal
Single-cell profiling unveils an exhaustion trajectory of ZNF683hi tissue-resident alveolar CD8+ T cells in checkpoint inhibitor pneumonitis
2026
·
Xiaoxiang Zhou
, Ziming Jiang
, et al.
·
Med
·
1
The Addition of Concurrent Immune Checkpoint Inhibitors for Chemoradiotherapy With Consolidative Immune Checkpoint Inhibitors in Unresectable Cancers: A Systematic Review and Meta‐Analysis
2026
·
Xu Tong
, Zhenting Liu
, et al.
·
International Journal of Cancer
Induction of cuproptosis enhances sensitivity and overcomes resistance to osimertinib in lung cancer
2025
·
Yi-Bo Gao
, Jia-Ming Xie
, et al.
·
Signal Transduction and Targeted Therapy
·
7
PDF
Metformin decelerates aging clock in male monkeys
2024
·
Yuanhan Yang
, Xiaoyong Lu
, et al.
·
Cell
·
263
Single-cell profiling identifies IL1Bhi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis
2024
·
Ziyue Zhou
, Xiaoxiang Zhou
, et al.
·
Nature Communications
·
53
PDF
Show more works
View as search